Do proton pump inhibitors modulate the efficacy of anti-PD-1/PD-L1 therapy? A retrospective study.

Mukherjee, Sarbajit; Ibrahimi, Sami; Khalid, Bilal; Roman, Darwin; Zhao, Daniel; Aljumaily, Raid

Mukherjee, Sarbajit; Ibrahimi, Sami; Khalid, Bilal; Roman, Darwin; Zhao, Daniel; Aljumaily, Raid.

Afiliación

Mukherjee S; 1 Division of Hematology-Oncology, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Ibrahimi S; 1 Division of Hematology-Oncology, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Khalid B; 1 Division of Hematology-Oncology, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Roman D; 2 Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Zhao D; 3 Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Aljumaily R; 1 Division of Hematology-Oncology, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

J Oncol Pharm Pract ; 25(3): 762-764, 2019 04.

Article en En | MEDLINE | ID: mdl-29690815

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google